APELLIS PHARMACEUTICALS INC (APLS:NASDAQ)
$40.79 0.14 (0.3444%)
Analysed APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) News Sources
Gilead Expands Oncology Pipeline With $5B Tubulis Deal
09-04-2026
yahoo.com
Biogen’s Apellis Deal Reshapes Growth Outlook And Valuation Story
04-04-2026
yahoo.com
Where the New Houses Are—and What That Says About Growth
03-04-2026
yahoo.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Astra-Zeneca, Brinker, e.l.f. Beauty, Freeport-McMoran, Vale, Wingstop, Wix.com, and More
02-04-2026
247wallst.com
How The Apellis Pharmaceuticals (APLS) Investment Story Is Shifting With New Deals And Analyst Revisions
01-04-2026
yahoo.com
Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio
01-04-2026
yahoo.com
Disney upgraded, Nike downgraded: Wall Street's top analyst calls
01-04-2026
yahoo.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More
01-04-2026
247wallst.com
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?
01-04-2026
yahoo.com
Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout
01-04-2026
pharmaceutical-technology.com
What is the current price of APELLIS PHARMACEUTICALS INC (APLS:NASDAQ)?
The current price of APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) is $40.79.
APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) since the previous trading day is $0.14.
APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) since the previous trading day is 0.3444%.
What is the most recent average sentiment score for APELLIS PHARMACEUTICALS INC (APLS:NASDAQ)?
The most recent average sentiment score for APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for APELLIS PHARMACEUTICALS INC (APLS:NASDAQ)?
The most recent sentiment for APELLIS PHARMACEUTICALS INC (APLS:NASDAQ) is .
SEC-8K** Filing Available For APELLIS PHARMACEUTICALS INC (APLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.